Resistance to Irinotecan ;CPT-11) activates Epidermal Growth Factor Receptor/Nuclear Factor Kappa B and Increases Cellular Metastasis and Autophagy in LoVo Colon Cancer Cells

ASIA unversity > 管理學院 > 國際企業學系 > 期刊論文 > Item 310904400/79748

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/79748

题名:	Resistance to Irinotecan;CPT-11) activates Epidermal Growth Factor Receptor/Nuclear Factor Kappa B and Increases Cellular Metastasis and Autophagy in LoVo Colon Cancer Cells
作者:	Ming-Cheng, C;Chen, Ming-Cheng;Le, Nien-Hung;Lee, Nien-Hung;Tsung-Jung, H;Ho, Tsung-Jung;Hs, Hsi-Hsien;Hsu, Hsi-Hsien;郭家驊;郭薇雯;Lin, Yueh-Min;Lin, Yueh-Min;蔡輔仁;Tsai, Fuu-Jen;蔡長海;黃志揚;HUANG, CHIH-YANG
贡献者:	健康產業管理學系
关键词:	Autophagy;CPT-11;Chemoresistance;Metastasis;NF-κB
日期:	2014
上传时间:	2014-06-05 04:02:38 (UTC+0)
摘要:	Chemotherapy is usually applied to treat colon cancer but leads to chemoresistance, and increased metastasis and invasion. The main focus of this study is to observe effects of resistance to irinotecan (CPT-11) on metastasis, invasion and autophagy in CPT-11 resistant (CPT-11-R) LoVo colon cancer cells. CPT-11, a topoisomerase I inhibitor and a first-line chemotherapeutic drug, is used to treat colon cancer. CPT-11-R cells were constructed in a step-wise fashion with increasing CPT-11 doses. The CPT-11-R strain had a significantly lower expression of Wnt/β-catenin pathway, but induced an EGFR/IKKα/β/NF-κB pathway with elevated cell cycle, metastasis and basal autophagy. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
關聯:	CANCER LETTERS;349(1):51-60.
显示于类别:	[國際企業學系] 期刊論文

文件中的档案:

档案	大小	格式	浏览次数
index.html	0Kb	HTML	506	检视/开启

在ASIAIR中所有的数据项都受到原著作权保护.